Interventions for treating pain and disability in adults with complex regional pain syndrome- an overview of systematic reviews

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 4, 2013, Pages

  O'Connell, Neil E ^a   Wand, Benedict M ^b   Mcauley, James ^c   Marston, Louise ^d   Moseley, G Lorimer ^e  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF NOTRE DAME   (Australia)

^c NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CAPSAICIN; CARBAMAZEPINE; CLODRONIC ACID; CLONIDINE; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DEXTROMETHORPHAN; DIMETHYL SULFOXIDE; DOXEPIN; GABAPENTIN; KETAMINE; LIDOCAINE; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PAMIDRONIC ACID; PHENTOLAMINE; PLACEBO; SARPOGRELATE; SCAVENGER; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG; ADRENERGIC RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; GUANETHIDINE;

ADULT; BODY WEIGHT DISORDER; BURN; COCHRANE LIBRARY; COGNITIVE BEHAVIORAL THERAPY; COMPLEX REGIONAL PAIN SYNDROME; COMPLEX REGIONAL PAIN SYNDROME TYPE I; DIARRHEA; DISABILITY; DISEASE SEVERITY; DIZZINESS; DYSPHORIA; FATIGUE; FEVER; FIBROMYALGIA; GASTROINTESTINAL DISEASE; HALLUCINATION; HAND EDEMA; HEADACHE; HEART PALPITATION; HUMAN; HYPOCALCEMIA; INFLUENZA; INJECTION SITE REACTION; NAUSEA; NEUROPATHIC PAIN; OCCUPATIONAL THERAPY; PAIN; PERIPHERAL EDEMA; PHYSIOTHERAPY; PRIORITY JOURNAL; PSYCHOTHERAPY; REHABILITATION; REVIEW; SKIN DISCOLORATION; SOMNOLENCE; SURGICAL TECHNIQUE; SWELLING; SYMPATHETIC NERVE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; VOMITING; ANALGESIA; DISABLED PERSON; LITERATURE; META ANALYSIS; METHODOLOGY; NERVE BLOCK;

ADULT; ANALGESICS; CALCITONIN; COMPLEX REGIONAL PAIN SYNDROMES; DIPHOSPHONATES; DISABLED PERSONS; GUANETHIDINE; HUMANS; IMAGERY (PSYCHOTHERAPY); KETAMINE; NERVE BLOCK; PAIN MANAGEMENT; PHYSICAL THERAPY MODALITIES; REVIEW LITERATURE AS TOPIC; SYMPATHOLYTICS;

EID: 84886858847     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD009416.pub2     Document Type: Review

References (243)

1. Brunner F, Schmid A, Kissling R, Held U, Bachmann L M. Biphosphonates for the therapy of complex regional pain syndrome I - systematic review. European Journal of Pain 2009;13(1):17-21.
2. Cepeda MS, Carr D B, Lau J. Local anesthetic sympathetic blockade for complex regional pain syndrome. [Review]. Cochrane Database of Systematic Reviews 2005, Issue 4.
3. Challapalli V, Tremont-Lukats I, McNicol ED, Lau J, Carr DB. Systemic administration of local anesthetic agents to relieve neuropathic pain. [Review]. Cochrane Database of Systematic Reviews 2005, Issue 4.
4. Chauvineau V, Codine P, Herisson C, Pellas F, Pelissier J. What is the place of biphosphonates in the treatment of complex regional pain syndrome I?. Annales de Readaptation et de Medecine Physique [Annals of Physical Medicine and Readaptation] 2005;48(3):150-7.
5. Collins S, Sigtermans M J, Dahan A, Zuurmond WW, Perez RS. NMDA receptor antagonists for the treatment of neuropathic pain. Pain Medicine 2010;11(11):1726-42.
6. Daly AE Bialocerkowski A. Does evidence support physiotherapy management of adult Complex Regional Pain Syndrome Type One? A systematic review. European Journal of Pain 2009; Vol. 13, issue 4:339-53.
7. Fischer SGL, Zuurmond WWA, Birklein F, Loer SA, Perez RSGM. Anti-inflammatory treatment of Complex Regional Pain Syndrome. Pain 2010;151(2):251-6.
8. Forouzanfar T, Koke AJ, van Kleef M, Weber WE. Treatment of complex regional pain syndrome type I. European Journal of Pain 2002; Vol. 6, issue 2:105-22.
9. Jadad AR, Carroll D, Glynn CJ, McQuay HJ. Intravenous regional sympathetic blockade for pain relief in reflex sympathetic dystrophy: a systematic review and a randomized, double-blind crossover study. Journal of Pain and Symptom Management 1995;10(1):13-20.
10. Lu Y-M Fu L-X Mu J Xu H-J Qi Y. Acupuncture for post stroke shoulder hand syndrome: A systematic review. Chinese Journal of Evidence-Based Medicine 2009; Vol. 9, issue 9:976-8.
11. Mailis-Gagnon A, Furlan AD, Sandoval JA, Taylor R. Spinal cord stimulation for chronic pain. Cochrane Database of Systematic Reviews 2004, Issue 3.
12. Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database of Systematic Reviews 2011, Issue 3.
13. O'Connell NE, Wand BM, Marston L, Spencer S, DeSouza LH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database of Systematic Reviews 2010, Issue 9.
14. Perez RS, Kwakkel G, Zuurmond WW, de Lange JJ. Treatment of reflex sympathetic dystrophy (CRPS type 1): a research synthesis of 21 randomized clinical trials. Journal of Pain and Symptom Management 2001;21(6):511-26.
15. Rothgangel AS, Braun SM, Beurskens AJ, Seitz RJ, Wade DT. The clinical aspects of mirror therapy in rehabilitation: a systematic review of the literature. International Journal of Rehabilitation Research 2011;34(1):1-13.
16. Simpson E, Duenas A, Holmes M, Papaioannou D, Chilcott J. Spinal cord stimulation for chronic pain of neuropathic or ischaemic origin: systematic review and economic evaluation. Health Technology Assessment 2009;13(17):1-179.
17. Smith TO. How effective is physiotherapy in the treatment of complex regional pain syndrome type I? A review of the literature. Musculoskeletal Care 2005;3(4):181-200.
18. Straube S, Derry S, Moore RA, McQuay HJ. Cervico-thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome. Cochrane Database of Systematic Reviews 2010, Issue 7.
19. Tran DQH, Duong S, Bertini P, Finlayson R. Treatment of complex regional pain syndrome: A review of the evidence. Canadian Journal of Anesthesia 2010; Vol. 57, issue 2:149-66.
20. Albazaz R, Wong YT, Homer-Vanniasinkam S. Complex regional pain syndrome: a review. Annals of Vascular Surgery 2008;22(2):297-306.
21. Athie-Garcia JM, Espinoza JA. Reflex sympathetic dystrophy. Case report and literature review [Distrofia simpatica refleja en el postoperatorio inmediato. Reporte de un caso y revision de la literature]. Revista Mexicana Anestesiologia 1992;15:30-2.
22. Attal N, Cruccu G, Baron R, Haanpaa M, Hansson P, Jensen TS, et al.EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European Journal of Neurology 2010;17(9):1113-23.
23. Baidya DK, Agarwal A, Khanna P, Arora MK. Pregabalin in acute and chronic pain. Journal of Anaesthesiology Clinical Pharmacology 2011; Vol. 27, issue 3:307-14.
24. Bal R, Legree L, Diwan S. Nonopioid analgesic pipeline: Pharmacology, safety, tolerability, and potential advantages over established agents. Techniques in Regional Anesthesia and Pain Management 2010; Vol. 14, issue 2:75-85.
25. Beckerman H, de Bie RA, Bouter LM, de Cuyper HJ, Oostendorp RAB. De effectiviteit van lasertherapie bij aandoeningen van het bewegingsapparaat en de huid. Nederlands Tijdschrift voor Fysiotherapie [Dutch Journal of Physical Therapy] 1990;100(12):306-16.
26. Bekkering GE, Soares-Weiser K, Reid K, Kessels AG, Dahan A, Treede RD, et al.Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Current Medical Research and Opinion 2011; Vol. 27, issue 7:1477-91.
27. Bernstein RM. Injections and surgical therapy in chronic pain. Clinical Journal of Pain 2001; Vol. 17, issue 4:S94-S104.
28. Bittar RG, Kar-Purkayastha I, Owen SL, Bear RE, Green A, Wang S, et al.Deep brain stimulation for pain relief: A meta-analysis. Journal of Clinical Neuroscience 2005; Vol. 12, issue 5:515-9.
29. Blonk MI, Koder BG, van den Bemt PMLA Huygen FJPM. Use of oral ketamine in chronic pain management: A review. European Journal of Pain 2010; Vol. 14, issue 5:466-72.
30. Blum K, Chen AL, Chen TJ, Prihoda TJ, Schoolfield J, Dinubile N, et al.The H-Wave(R) device is an effective and safe non-pharmacological analgesic for chronic pain: a meta-analysis. Advances in Therapy 2008;25(7):644-57.
31. Bronfort G, Haas M, Evans R, Leininger B, Triano J. Effectiveness of manual therapies: the UK evidence report. Chiropractic & Osteopathy 2010;18:3.
32. Campbell FA, Tramer MR, Carroll D, Reynolds DJ, Moore RA, McQuay HJ. Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review. BMJ 2001;323(7303):13-6.
33. Cao H, Han M, Li X, Dong S, Shang Y, Wang Q, et al.Clinical research evidence of cupping therapy in China: a systematic literature review. BMC Complementary and Alternative Medicine 2010;10:70.
34. Cepeda MS Lau J Carr D. Defining the therapeutic role of local anesthetic sympathetic blockade in complex regional pain syndrome: A narrative and systematic review. Clinical Journal of Pain 2002; Vol. 18, issue 4:216-33.
35. Claydon L, Fris C, Lucas R, Scott N, Silk L. The effects of exercise on pain relief in neuropathic pain conditions: A systematic review. European Journal of Pain. Supplements Vol. 4:129.
36. Covarrubias-Gomez A. The role of cannabinoids to manage pain. Revista Mexicana de Anestesiologia [Mexican Review of Anesthesiology] 2008; Vol. 31, issue 3:191-200.
37. del Pozo E. The effectiveness of levetiracetam in the treatment of neuropathic pain. Revista de neurologia [Review of Neurology] 2011; Vol. 53, issue 2:65-72.
38. Derry S, Lloyd R, Moore RA, McQuay HJ. Topical capsaicin for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 4.
39. Duhmke RM, Cornblath DD, Hollingshead JR. Tramadol for neuropathic pain. Cochrane Database of Systematic Reviews 2004, Issue 2.
40. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al.Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain 2007; Vol. 132, issue 3:237-51.
41. Eccles NK. A critical review of randomized controlled trials of static magnets for pain relief. Journal of Alternative and Complementary Medicine 2005;11(3):495-509.
42. Eisenberg E, McNicol ED, Carr DB. Opioids for neuropathic pain. Cochrane Database of Systematic Reviews 2006, Issue 3.
43. Ellis RF, Hing W. Neural mobilization: A systematic review of randomized controlled trials with an analysis of therapeutic efficacy. Journal of Manual and Manipulative Therapy 2008; Vol. 16, issue 1:8-22.
44. Ezendam D, Bongers RM, Jannink MJ. Systematic review of the effectiveness of mirror therapy in upper extremity function. Disability and Rehabilitation 2009;31(26):2135-49.
45. Finnerup NB, Otto M, McQuay HJ, Jensen TS, Sindrup SH. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118(3):289-305.
46. Finnerup NB, Otto M, Jensen TS, Sindrup SH. An evidence-based algorithm for the treatment of neuropathic pain. Medgenmed [Medscape General Medicine] 2007;9(2):36.
47. Finnerup NB, Sindrup SH, Jensen TS. The evidence for pharmacological treatment of neuropathic pain. Pain 2010; Vol. 150, issue 3:573-81.
48. Flórez S, León M, Torres M, Reyes F, Serpa JC, Ríos AM. Pharmacological management of neuropathic pain [Manejo farmacológico del dolor neuropático]. Revista Columbia de Anestesiologia [Columbian Anesthesiology Journal] 2009;37(4):358-74.
49. Fulop AM, Dhimmer S, Deluca JR, Johanson DD, Lenz RV, Patel KB, et al.A meta-analysis of the efficacy of laser phototherapy on pain relief. Clinical Journal of Pain 2010; Vol. 26, issue 8:729-36.
50. Geertzen JHB. Development of guidelines for the diagnostics and multidisciplinary treatment of Complex Regional Pain Syndrome Type I. Journal of Neuropathic Pain & Symptom Palliation 2006;2(3):73-7.
51. Geurts ACH, Visschers BAJ, van Limbeek J, Ribbers GM. Systematic review of aetiology and treatment of post-stroke hand oedema and shoulder-hand syndrome. Scandinavian Journal of Rehabilitation Medicine 2000;32(1):4-10.
52. Gill D, Derry S, Wiffen PJ, Moore RA. Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults (Review). Cochrane Database of Systematic Reviews 2011, Issue 10.
53. Gonzalez-Escalada JR, Rodriguez MJ, Camba MA, Portoles A, Lopez R. Recommendations for the treatment of neuropathic pain. Revista de la Sociedad Espanola del Dolor [Spanish Journal of Pain] 2009; Vol. 16, issue 8:445-67.
54. Goodyear-Smith F, Halliwell J. Anticonvulsants for neuropathic pain: Gaps in the evidence. Clinical Journal of Pain 2009; Vol. 25, issue 6:528-36.
55. Gottschild S, Kroling P. Vibratory massage: A review of physiological effects and therapeutical efficacy. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin [Journal of Physical and Rehabilitation Medicine] 2003; Vol. 13, issue 2:85-95.
56. Granot R, Day RO, Cohen ML, Murnion B, Garrick R. Targeted pharmacotherapy of evoked phenomena in neuropathic pain: a review of the current evidence. Pain Medicine 2007; Vol. 8, issue 1:48-64.
57. Harden RN. Pharmacotherapy of complex regional pain syndrome. American Journal of Physical Medicine & Rehabilitation 2005;84(3):S17-28.
58. Harden RN. Interdisciplinary management/functional restoration. Journal of Neuropathic Pain & Symptom Palliation 2006;2(3):57-68.
59. Haroutiunian S, Drennan DA, Lipman AG. Topical NSAID therapy for musculoskeletal pain. Pain Medicine 2010;11(4):535-49.
60. Hassantash SA, Afrakhteh M, Maier RV. Causalgia: a meta-analysis of the literature. Archives of Surgery 2003;138(11):1226-31.
61. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesthesia and Analgesia 2003;97(6):1730-9.
62. Johnson MI, Bjordal J. Transcutaneous electrical nerve stimulation for the management of painful conditions: Focus on neuropathic pain. Expert Review of Neurotherapeutics 2011; Vol. 11, issue 5:735-53.
63. Kingery WS. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain 1997;73(2):123-39.
64. Koltzenburg M. Painful neuropathies. Current Opinion in Neurology 1998; Vol. 11, issue 5:515-21.
65. Kouroukli I. Neuropathic pain management: Efficacy, safety, complications of interventional techniques: Radiofrequency techniques. European Journal of Pain Supplements 2010; Vol. 4:10.
66. Leite LC, Mondin L. Compex regional pain syndrome [Sindrome de dor regional complexa]. Revista científica da Associação Médica de Caxias [Journal of the Medical Association of Caxias] 2000;9(2):50-3.
67. Linde K, Vickers A, Hondras M, ter Riet G, Thormählen J, Berman B, et al.Systematic reviews of complementary therapies - an annotated bibliography. Part 1: Acupuncture. BMC Complementary and Alternative Medicine 2001;1(3).
68. Lord SM, Bogduk N. Radiofrequency procedures in chronic pain. Best Practice & Research. Clinical Anaesthesiology 2002;16(4):597-617.
69. Manchikanti L, Vallejo R, Manchikanti KN, Benyamin RM, Datta S, Christo PJ. Effectiveness of long-term opioid therapy for chronic non-cancer pain. Pain Physician 2011;14:E133-56.
70. Martinez JE, Goldenberg J, Pollak DF, Atra E. Reflex sympathetic dystrophy: a literature review. Revista Brasileira Reumatologia [Brazilian Journal of Rheumatology] 1993;33(2):61-4.
71. McHardy A, Hoskins W, Pollard H, Onley R, Windsham R. Chiropractic treatment of upper extremity conditions: A systematic review. Journal of Manipulative and Physiological Therapeutics 2008;31(2):146-59.
72. McQuay HJ, Moore RA, Eccleston C, Morley S, Williams AC. Systematic review of outpatient services for chronic pain control. Health Technology Assessment 1997;1(6):1-135.
73. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ. Pregabalin for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2009, Issue 3.
74. Motsch J, Kamler M. alpha2-adrenergic agonists. Use in chronic pain - A meta-analysis. Schmerz [Pain] 1997; Vol. 11, issue 5:339-44.
75. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ, et al.Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Research & Management 2007;12(1):13-21.
76. Namaka M, Gramlich CR, Ruhlen D, Melanson M, Sutton I, Major J. A treatment algorithm for neuropathic pain. Clinical Therapeutics 2004;26(7):951-79.
77. Namaka M, Leong C, Grossberndt A, Klowak M, Turcotte D, Esfahani F, et al.A treatment algorithm for neuropathic pain: an update. Consultant Pharmacist 2009;24(12):885-902.
78. Neira LV, Neira MS, Guzman-Sarzon RM, Perez RC. Algodystrophy: A clinical therapeutic study [Algodistrofia: Estudio clinical y terapeutico]. Diagnostico [Diagnosis] 1988;22:29-43.
79. Nilsagard Y, Hammer A, Lovgren A, Frick L. Physiotherapy treatment of shoulder pain after stroke -- prevention and intervention. Nordisk Fysioterapi [Nordic Physiotherapy] 2004;8(4):174-82.
80. Nnoaham KE, Kumbang J. Transcutaneous electrical nerve stimulation (TENS) for chronic pain. Cochrane Database of Systematic Reviews 2008, Issue 3.
81. Noble M, Treadwell JR, Tregear SJ, Coates VH, Wiffen PJ, Akafomo C, et al.Long-term opioid management for chronic noncancer pain. Cochrane Database of Systematic Reviews 2010, Issue 1.
82. North R. Spinal cord stimulation for neuropathic pain. European Journal of Pain Supplements 2010; Vol. 4:10-11.
83. Pappagallo M. Capsaicin (TRPV1 agonist) therapy for pain relief: Farewell or revival?. Clinical Journal of Pain 2008; Vol. 24, issue 2:142-54.
84. Patel VB, Manchikanti L, Singh V, Schultz DM, Hayek SM, Smith HS. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain. Pain Physician 2009;12:345-60.
85. Perez RS, Zollinger PE, Dijkstra PU, Thomassen-Hilgersom IL, Zuurmond WW, Rosenbrand KCJ, et al.Evidence based guidelines for complex regional pain syndrome type 1. BMC Neurology 2010;10.
86. Pittler MH, Brown EM, Ernst E. Static magnets for reducing pain: Systematic review and meta-analysis of randomized trials. Canadian Medical Association Journal 2007; Vol. 177, issue 7:736-42.
87. Pittler MH, Ernst E. Complementary therapies for neuropathic and neuralgic pain: systematic review. Clinical Journal of Pain 2008;24(8):731-3.
88. Plested M, Budhia S, Gabriel Z. Pregabalin, the lidocaine plaster and duloxetine in patients with refractory neuropathic pain: a systematic review. BMC Neurology 2010; Vol. 10:116.
89. Prescrire. Complex Regional pain syndrome type 1. Some treatments assessed versus placebo, limited efficacy. Prescrire International 2009;18(104):267-71.
90. Rauck RL, Wallace MS, Burton AW, Kapural L, North JM. Intrathecal ziconotide for neuropathic pain: a review. Pain Practice 2009;9(5):327-37.
91. Rehberg B. Evidence-based integrative pain medicine. European Journal of Integrative Medicine 2010; Vol. 2, issue 3:109-13.
92. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database of Systematic Reviews 2010, Issue 11.
93. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain: A Cochrane review. Journal of Neurology, Neurosurgery and Psychiatry 2010;81(12):1372-3.
94. Schestatsky P. Definition, diagnosis and treatment of neuropathic pain [Definicao, diagnostico e tratamento da dor neuropatica]. Publicação Científica do Hospital de Clínicas de Porto Alegre e Faculdade de Medicina da Universidade Federal do Rio Grande do Sul [Scientific Publication of the Hospital de Clinicas de Porto Alegre and Faculty of Medicine, Federal University of Rio Grande do Sul] 2008;28(3):177-87.
95. Seidel S, Aigner M, Ossege M, Pernicka E, Wildner B, Sycha T. Antipsychotics for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2008, Issue 4.
96. So PS, Jiang Y, Qin Y. Touch therapies for pain relief in adults. Cochrane Database of Systematic Reviews 2008, Issue 4.
97. Trescot A, Glaser SE, Hansen H, Benyamin R, Patel S, Manchikanti L. Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 2008;11:S181-S200.
98. Van den Berg P, Bierma-Zeinstra S, Koes B. Complex regional pain syndrome. A systematic review of its clinical manifestations and prognosis. Huisarts en Wetenschap [Family Practice] 2002; Vol. 45, issue 3:114-8.
99. Vergne-Salle P, Mejjad O, Javier RM, Maheu E, Fallut M, Glowinski J, Bertin P. Antiepileptic drugs to treat pain in rheumatic conditions. Recommendations based on evidence-based review of the literature and expert opinion. Joint, Bone, Spine 2009; Vol. 76, issue 1:75-85.
100. Vlassakov KV, Narang S, Kissin I. Local anesthetic blockade of peripheral nerves for treatment of neuralgias: systematic analysis. Anesthesia and Analgesia 2011;112(6):1487-93.
101. Watson C P, Gilron I, Sawynok J. A qualitative systematic review of head-to-head randomized controlled trials of oral analgesics in neuropathic pain. Pain Research and Management 2010; Vol. 15, issue 3:147-57.
102. Wetering EJVD, Lemmens KMM, Nieboer AP, Huijsman R. Cognitive and behavioral interventions for the management of chronic neuropathic pain in adults - A systematic review. European Journal of Pain 2010; Vol. 14, issue 7:670-81.
103. Wiedemann B. Ketamine for treatment of chronic pain: Meta-analysis. Schmerz 1997; Vol. 11, issue 4:276-81.
104. Wiffen PJ Rees J. Lamotrigine for acute and chronic pain. Cochrane Database of Systematic Reviews 2009, Issue 4.
105. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database of Systematic Reviews 2011, Issue 1.
106. Williams JA, Day M, Heavner J. Ziconotide: An update and review. Expert Opinion on Pharmacotherapy 2008; Vol. 9, issue 9:1575-83.
107. Zaccara G, Gangemi P, Perucca P, Specchio L. The adverse event profile of pregabalin: a systematic review and meta-analysis of randomized controlled trials. Epilepsia 2011;52(4):826-36.
108. Adami S, Fossaluzza V, Gatti D, Fracassi E, Braga V. Bisphosphonate therapy of reflex sympathetic dystrophy syndrome. Annals of the Rheumatic Diseases 1997;56(3):201-4.
109. Albrecht PJ, Hines S, Eisenberg E, Pud D, Finlay DR, Davar G, et al.Pathologic alterations of cutaneous innervation and vasculature in affected limbs from patients with complex regional pain syndrome. Pain 2006;120:244-66.
110. Ali Z, Raja SN, Wesselmann U, Fuchs PN, Meyer RA, Campbell JN. Intradermal injection of norepinephrine evokes pain in patients with sympathetically maintained pain. Pain 2000;88(2):161-8.
111. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al.GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401-6.
112. Becker LA, Oxman AD. Chapter 22: Overviews of reviews. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. The Cochrane Collaboration. Available from www.cochrane-handbook.org, 2011.
113. Bickerstaff DR, Kanis JA. The use of nasal calcitonin in the treatment of post-traumatic algodystrophy. British Journal of Rheumatology 1991;30(4):291-4.
114. Birklein F, Weber M, Neundörfer B. Increased skin lactate in complex regional pain syndrome: evidence for tissue hypoxia?. Neurology 2000;55(8):1213-5.
115. Birklein F, Schmelz M, Schifter S, Weber M. The important role of neuropeptides in complex regional pain syndrome. Neurology 2001;57:2179-84.
116. Blanchard J, Ramamurthy S, Walsh N, Hoffman J, Schoenfeld L. Intravenous regional sympatholysis: A double-blind comparison of guanethidine, reserpine, and normal saline. Journal of Pain and Symptom Management 1990;5(6):357-61.
117. BMJ Clinical Evidence. Default search strategies used for BMJ Clinical Evidence. http://clinicalevidence.bmj.com/ceweb/about/search_filters.jsp (accessed 13 April 2011).
118. Bonelli S, Conoscente F, Movilia PG. Regional intravenous guanethidine vs. stellate ganglion block in reflex sympathetic dystrophies: a randomized trial. Pain 1983;16(3):297-307.
119. Bounameaux HM, Hellemans H, Verhaeghe R. Ketanserin in chronic sympathetic dystrophy. An acute controlled trial. Clinical Rheumatology 1984;3(4):556-7.
120. Braus DF, Krauss JK, Strobel J. The shoulder-hand syndrome after stroke: A prospective clinical trial. Annals of Neurology 1994;36(5):728-33.
121. Bruehl S, Harden RN, Galer BS, Saltz S, Bertram M, Backonja M, et al.External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria. International Association for the Study of Pain. Pain 1999;81(1-2):147-54.
122. Bruehl S. Psychological interventions. In: Harden RN editor(s). Complex regional pain syndrome: treatment guidelines. Reflex Sympathetic Dystrophy Syndrome Association, 2006.
123. Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology 2010;113(3):713-25.
124. Burton AW. Interventional therapies. In: Harden NR editor(s). Complex Regional Pain Syndrome: Treatment Guidelines. Reflex Sympathetic Dystrophy Syndrome Association, 2006.
125. Cacchio A, De Blasis E, De Blasis V, Santilli V, Spacca G. Mirror therapy in complex regional pain syndrome type 1 of the upper limb in stroke patients. Neurorehabilitation and Neural Repair 2009;23(8):792-9.
126. Cacchio A, De Blasis E, Necozione S, Di Orio F, Santilli V. Mirror therapy for chronic complex regional pain syndrome type 1 and stroke. New England Journal of Medicine 2009;361(6):634-6.
127. Carroll I, Clark JD, Mackey S. Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Annals of Neurology 2009;65(3):348-51.
128. Chang N, Liu S. Combining acupuncture and rehabilitation therapies on shoulder hand syndrome: analysis on the effectiveness. Journal of the Fourth Military Medical University 2005;26(24):2295-7.
129. Cherot A, Amor B. [Etude randomisée sur 95 casde trios traiements: calsyn 100, visken, grisé fulvineet phentonium]. Revue du Rhumatisme et des Maladies Osteo- Articulaires [Journal of Rheumatic and Osteo-Articular Diseases] 1983;50:95-7.
130. Christensen K, Jensen EM, Noer I. The reflex dystrophy syndrome response to treatment with systemic corticosteroids. Acta Chirurgica Scandinavica 1982;148(8):653-5.
131. Cohen P, Uebelhart D. Indications of Pamidronate disodique(Aredia*) in the treatment of post traumatic or post surgical of the distal upper limb algodystrophies [Indications du Pamidronate disodique(Aredia*) dans le traitement des algodystrophies post-traumatiques ou post-chirurgicales de l'extrémité distale du membre supérieur]. In: Simon L, Pélissier J, Hérisson C editor(s). Progrès en MPR. Paris: Masson, 1998:510-4.
132. Cossins L, Okell RW, Cameron H, Simpson B, Poole HM, Goebel A. Treatment of complex regional pain syndrome in adults: A systematic review of randomized controlled trials published from June 2000 to February 2012. European Journal of Pain 2013;17(2):158-73.
133. de Mos M, de Bruijn AGJ, Huygen FJPM, Dieleman JP, Stricker BHC, Sturkenboom MCJM. The incidence of complex regional pain syndrome: a population-based study. Pain 2007;129(1-2):12-20.
134. de Mos M, Huygen FJPM, Dieleman JP, Koopman JSHA, Stricker BHC, Sturkenboom MCJM. Medical history and the onset of complex regional pain syndrome (CRPS). Pain 2008;139(2):458-66.
135. de Mos, Sturkenboom MCJM, Huygen FJPM. Current understandings on complex regional pain syndrome. Pain Practice 2009;9(2):86-99.
136. Dhar S, McGlone F, Dean J, Klenerman L. The temporal significance of the placebo response in reflex sympathetic dystrophy. Proceedings of the British Orthopaedic Research Society 1992;16:16-17.
137. Drummond PD, Finch PM, Skipworth S, Blockey P. Pain increases during sympathetic arousal in patients with complex regional pain syndrome. Neurology 2001;57(7):1296-303.
138. Drummond PD, Finch PM. Persistence of pain induced by startle and forehead cooling after sympathetic blockade in patients with complex regional pain syndrome. Journal of Neurology, Neurosurgery, and Psychiatry 2004;75(1):98-102.
139. Duman I, Ozdemir A, Tan AK, Dincer K. The efficacy of manual lymphatic drainage therapy in the management of limb edema secondary to reflex sympathetic dystrophy. Rheumatology International 2009;29(7):759-63.
140. Durmus A, Cakmak A, Disci R, Muslumanoglu L. The efficiency of electromagnetic field treatment in Complex Regional Pain Sydrome Type I. Disability and Rehabilitation 2004;26(9):537-45.
141. Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, et al.Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. Journal of Pain 2008;9(2):105-21.
142. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, et al.Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 2009;146(3):238-44.
143. Dworkin RH, Turk DC, Peirce-Sandner S, Baron R, Bellamy N, Burke LB, et al.Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations. Pain 2010;149(2):177-93.
144. Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, et al.Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations. Pain 2012;153(6):1148-58.
145. Eckmann MS, Ramamurthy S, Griffin JG. Intravenous regional ketorolac and lidocaine in the treatment of complex regional pain syndrome of the lower extremity: A randomized, double-blinded, crossover study. Clinical Journal of Pain 2011;27(3):203-6.
146. Ernst E, Resch KL, Fialka V, Ritter-Dittrich D, Alcamioglu Y, Chen O, et al.Traditional acupuncture for reflex sympathetic dystrophy: A randomised, sham-controlled, double-blind trial. Acupuncture in Medicine 1995;13(2):78-80.
147. Eypasch E, Lefering R, Kum CK, Troidl H. Probability of adverse events that have not yet occurred: a statistical reminder. BMJ 1995;311:619-20.
148. Fialka V, Resch KL, Ritter-Dietrich D, Alacamlioglu Y, Chen O, Leitha T, et al.Acupuncture for reflex sympathetic dystrophy. Archives of Internal Medicine 1993;153:661.
149. Fialka V, Korpan M, Saradeth T, Paternostro-Slugo T, Hexel O, Frischenschlager O, et al.Autogenic training for reflex sympathetic dystrophy: A pilot study. Complementary Therapies in Medicine 1996;4:103-5.
150. Finch PM, Knudsen L, Drummond PD. Reduction of allodynia in patients with complex regional pain syndrome:A double-blind placebo-controlled trial of topical ketamine. Pain 2009; Vol. 146:18-25.
151. Fischer MJ, Reiners A, Kohnen R, Bernateck M, Gutenbrunner C, Fink M, et al.Do occlusal splints have an effect on complex regional pain syndrome? a randomized, controlled proof-of-concept trial. Clinical Journal of Pain 2008;24(9):776-83.
152. Frade LC, Lauretti GR, Lima IC, Pereira NL. The antinociceptive effect of local or systemic parecoxib combined with lidocaine/clonidine intravenous regional analgesia for complex regional pain syndrome type I in the arm. Anesthesia and Analgesia 2005;101(3):807-11.
153. Friez L, Pere G, Breuillard PH, Meigan S. Comparison of treatment with griseofulvin, betablockers and calcitonin in 55 cases of post traumatic algoneurodystrophy [Comparaison du traiement par la griseofulvine, les betabloquants et la calcitonine dans 55 cas d' algoneurodystrophie post-traumatique]. Revue du Rhumatisme et des Maladies Osteo-Articulaires [Journal of Rheumatic and Osteo-Articular Diseases] 1982;49:857-60.
154. Geertzen JHB, De Bruijn H, De Bruijn-Kofman AT, Arendzen JH. Reflex sympathetic dystrophy: Early treatment and psychological aspects. Archives of Physical Medicine and Rehabilitation 1994;75(4):442-6.
155. Geha PY, Baliki MN, Harden RN, Bauer WR, Parrish TB, Apkarian AV. The brain in chronic CRPS pain: abnormal gray-white matter interactions in emotional and autonomic regions. Neuron 2008;60(4):570-81.
156. Glynn CJ, Stannard S, Collins PA, Casale R. The role of peripheral sudomotor blockade in the treatment of patients with sympathetically maintained pain. Pain 1993;53(1):39-42.
157. Gobelet C, Meier J-L, Schaffner W. Calcitonin and reflex sympathetic dystrophy syndrome. Clinical Rheumatology 1986;5(3):382-8.
158. Gobelet C, Waldburger M, Meier JL. The effect of adding calcitonin to physical treatment on reflex sympathetic dystrophy. Pain 1992;48(2):171-5.
159. Goebel A, Baranowski A, Maurer K, Ghiai A, McCabe C, Ambler G. Intravenous immunoglobulin treatment of the complex regional pain syndrome: a randomized trial. Annals of Internal Medicine 2010;152(3):152-8.
160. Goebel A, Barker CH, Turner-Stokes L, et al.Complex regional pain syndrome in adults: UK guidelines for diagnosis, referral and management in primary and secondary care. Royal College of Physicians. London 2011.
161. Goris RJ, Dongen LM, Winters HA. Are toxic oxygen radicals involved in the pathogenesis of reflex sympathetic dystrophy?. Free Radical Research Communications 1987;3(1-5):13-8.
162. Groeneweg G, Huygen FJPM, Niehof SP, Wesseldijk F, Bussmann JBJ, Schasfoort FC, et al.Effect of tadalafil on blood flow, pain, and function in chronic coldComplex Regional Pain Syndrome: a randomized controlled trial. BMC Musculoskeletal Disorders 2008; Vol. 9:143.
163. Gustin SM, Schwarz A, Birbaumer N, Sines N, Schmidt AC, Veit R, et al.NMDA-receptor antagonist and morphine decrease CRPS-pain and cerebral pain representation. Pain 2010;151(1):69-76.
164. Hanna MH, Peat SJ. Ketanserin in reflex sympathetic dystrophy. A double-blind placebo controlled cross-over trial. Pain 1989;38(2):145-50.
165. Harden RN, Bruehl S. Introduction and diagnostic considerations. In: Harden RN editor(s). Complex regional pain syndrome: treatment guidelines. Reflex Sympathetic Dystrophy Syndrome Association, 2006.
166. Harden RN. Pharmacotherapy. In: Harden RN editor(s). Complex regional pain syndrome: treatment guidelines. Reflex Sympathetic Dystrophy Syndrome Association, 2006.
167. Harden RN, Swan M, Costa BR, Barthel J, King AL. Interdisciplinary management. In: Harden RN editor(s). Complex regional pain syndrome: treatment guidelines. Reflex Sympathetic Dystrophy Syndrome Association, 2006.
168. Hord AH, Rooks MD, Stephens BO, Rogers HG, Fleming LL. Intravenous regional bretylium and lidocaine for treatment of reflex sympathetic dystrophy: A randomized, double-blind study. Anesthesia and Analgesia 1992;74(6):818-21.
169. Jin Y, Wang J, Wang An. Acupuncture with rehabilitation therapies on shoulder hand syndrome: 40 observational cases. Journal of Clinical Acupuncture and Moxibustion 2007;23(1):14-5.
170. Kalita J, Vajpayee A, Misra UK. Comparison of prednisolone with piroxicam in complex regional pain syndrome following stroke: A randomized controlled trial. QJM - Monthly Journal of the Association of Physicians 2006;99(2):89-95.
171. Kemler MA, Barendse GAM, Van Kleef M, De Vet HCW, Rijks CPM, Furnée CA, et al.Spinal cord stimulation in patients with chronic reflex sympathetic dystrophy. New England Journal of Medicine 2000;343(9):618-24.
172. Kemler MA, Reulen JPH, Barendse GAM, Van Kleef M, De Vet HCW, Van Den Wildenberg FAJM. Impact of spinal cord stimulation on sensory characteristics in complex regional pain syndrome type I: A randomized trial. Anesthesiology 2001;95(1):72-80.
173. Kemler MA, Furnée CA. Economic evaluation of spinal cord stimulation for chronic reflex sympathetic dystrophy. Neurology 2002;59(8):1203-9.
174. Kemler MA, De Vet HCW, Barendse GAM, Van Den Wildenberg FAJM, Van Kleef M. The effect of spinal cord stimulation in patients with chronic reflex sympathetic dystrophy: Two years' follow-up of the randomized controlled trial. Annals of Neurology 2004;55(1):13-8.
175. Kemler MA, De Vet HCW, Barendse GAM, Van Den Wildenberg FAJM, Van Kleef M. Spinal cord stimulation for chronic reflex sympathetic dystrophy - Five-year follow-up. New England Journal of Medicine 2006;354(22):2394-6.
176. Kettler RE, Abram SE. Intravenous regional droperidol in the management of reflex sympathetic dystrophy: A double-blind, placebo-controlled, crossover study. Anesthesiology 1988;69(6):933-6.
177. Kho KH. The impact of acupuncture on pain in patients with reflex sympathetic dystrophy. The Pain Clinic 1995;8(1):59-61.
178. Koban M, Leis S, Schultze-mosgau S, Birklein F. Tissue hypoxia in complex regional pain syndrome. Plastic and Reconstructive Surgery 2003;104:149-57.
179. Korpan MI, Dezu Y, Scneider B, Leitha T, Fialka-Moser V. Acupuncture in the treatment of posttraumatic pain syndrome. Acta Orthopaedica Belgica 1999;65:197-201.
180. Lefaucheur JP. Principles of therapeutic use of transcranial and epidural cortical stimulation. Clinical Neurophysiology 2008;119(10):179-84.
181. Lewis JS, Kersten P, Mccabe CS, McPherson KM, Blake DR. Body perception disturbance: a contribution to pain in complex regional pain syndrome (CRPS). Pain 2007;133(1-3):111-9.
182. Liu D, Zhang X. Effect of acupuncture on reflex sympathetic dystrophy syndrome (RSDS). Modern Journal of Integrated Chinese Traditional and Western Medicine 2006;15(3):326-7.
183. Livingstone JA, Atkins RM. Intravenous regional guanethidine blockade in the treatment of post-traumatic complex regional pain syndrome type 1 (algodystrophy) of the hand. Journal of Bone and Joint Surgery - Series B 2002;84(3):380-6.
184. Lotze M, Moseley GL. Role of distorted body image in pain. Current Rheumatology Reports 2007;9(6):488-96.
185. Lukovic TZ, Ilic KP, Jevtic M, Toncev G. Corticosteroids and physical agents in treatment of complex regional pain syndrome type I. Medicus 2006;7(2):70-2.
186. Maihöfner C, Handwerker HO, Neundörfer B, Birklein F. Cortical reorganization during recovery from complex regional pain syndrome. Neurology 2004;63(4):693-701.
187. Manicourt D-H, Brasseur J-P, Boutsen Y, Depreseux G, Devogelaer J-P. Role of alendronate in therapy for posttraumatic complex regional pain syndrome type I of the lower extremity. Arthritis and Rheumatism 2004;50(11):3690-7.
188. Manjunath PS, Jayalakshmi TS, Dureja GP, Prevost AT. Management of lower limb complex regional pain syndrome type 1: An evaluation of percutaneous radiofrequency thermal lumbar sympathectomy versus phenol lumbar sympathetic neurolysis - A pilot study. Anesthesia and Analgesia 2008;106(2):647-9.
189. Marinus J, Moseley GL, Birklein F, Baron R, Maihöfner C, Kingery WS, et al.Clinical features and pathophysiology of complex regional pain syndrome. Lancet Neurology 2011;10(7):637-48.
190. McCabe CS, Haigh RC, Blake DR. Mirror visual feedback for the treatment of complex regional pain syndrome (Type 1). Current Pain and Headache Reports 2008;12(2):103-7.
191. Merskey H, Bogduk N. Classification of chronic pain: Descriptions of chronic pain syndromes and definitions of pain terms. Classification of chronic pain: descriptions of chronic pain syndromes and definitions of pain terms. 2nd Edition. Seattle: IASP Press, 1994.
192. Moore RA, Barden J, Derry S, McQuay HJ. Managing potential publication bias. In: McQuay HJ, Kalso E, Moore RA editor(s). Systematic reviews in pain research: methodology refined. Seattle: IASP Press, 2008:15-23.
193. Moore RS, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, et al."Evidence" in chronic pain - Establishing best practice in the reporting of systematic reviews. Pain 2010;150(3):386-9.
194. Moseley GL. Graded motor imagery is effective for long-standing complex regional pain syndrome: a randomised controlled trial. Pain 2004;108:192-8.
195. Moseley GL. Is successful rehabilitation of complex regional pain syndrome due to sustained attention to the affected limb? A randomised clinical trial. Pain 2005;114(1-2):54-61.
196. Moseley GL. Graded motor imagery for pathologic pain: A randomized controlled trial. Neurology 2006;67(12):2129-34.
197. Moseley GL, Zalucki NM, Wiech K. Tactile discrimination, but not tactile stimulation alone, reduces chronic limb pain. Pain 2008;137:600-8.
198. Munts AG, van der Plas AA, Voormolen JH, Marinus J, Teepe-Twiss IM, Onkenhout W, et al.Intrathecal glycine for pain and dystonia in complex regional pain syndrome. Pain 2009;146(1-2):199-204.
199. Munts AG, van der Plas AA, Ferrari MD, Teepe-Twiss IM, Marinus J, van Hilten JJ. Efficacy and safety of a single intrathecal methylprednisolone bolus in chronic complex regional pain syndrome. European Journal of Pain 2010;14(5):523-8.
200. Nelson DV, Stacey BR. Interventional therapies in the management of complex regional pain syndrome. Clinical Journal of Pain 2006;22(5):438-42.
201. Niehof SP, Huygen FJPM, van der Weerd RWP, Westra M, Zijlstra FJ. Thermography imaging during static and controlled thermoregulation in complex regional pain syndrome type 1: diagnostic value and involvement of the central sympathetic system. Biomedical Engineering Online 2006;5:30.
202. Nüesch E, Trelle S, Reichenbach S, Rutjes AWS, Tschannen B, Altman DG, et al.Small study effects in meta-analyses of osteoarthritis trials: Meta-epidemiological study. BMJ 2010;341(7766):241.
203. Oaklander AL, Fields HL. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small-fiber neuropathy?. Annals of Neurology 2009;65(6):629-38.
204. Oerlemans HM, Goris RJA, De Boo T, Oostendorp RAB. Do physical therapy and occupational therapy reduce the impairment percentage in reflex sympathetic dystrophy?. American Journal of Physical Medicine and Rehabilitation 1999;78(6):533-9.
205. Oerlemans HM, Oostendorp RAB, De Boo T, Goris RJA. Pain and reduced mobility in complex regional pain syndrome I: Outcome of a prospective randomised controlled clinical trial of adjuvant physical therapy versus occupational therapy. Pain 1999;83(1):77-83.
206. Oerlemans HM, Oostendorp RAB, De Boo T, Van Der Laan L, Severens JL, Goris RJA. Adjuvant physical therapy versus occupational therapy in patients with reflex sympathetic dystrophy/complex regional pain syndrome type i. Archives of Physical Medicine and Rehabilitation 2000; Vol. 81, issue 1:49-56.
207. Ogawa S, Suzuki H, Shiotani Ml, Ooseto K, Masuda Y, Kawachi S, et al.A randomized clinical trial of sarpogrelate hydrochloride for neuropathic pain in patients with post-herpetic neuralgia and reflex sympathetic dystrophy. Pain Clinic 1998; Vol. 11, issue 2:125-32.
208. Perez RSGM, Zuurmond WWA, Bezemer PD, Kuik DJ, Van Loenen AC, De Lange JJ, et al.The treatment of complex regional pain syndrome type I with free radical scavengers: A randomized controlled study. Pain 2003;102(3):297-307.
209. Perez RS, Pragt E, Geurts J, Zuurmond WW, Patijn J, van Kleef M. Treatment of patients with complex regional pain syndrome type I with mannitol: A prospective, randomized, placebo-controlled, double-blinded study. Journal of Pain 2008;9(8):678-86.
210. Picarelli H, Teixeira MJ, de Andrade DC, Myczkowski ML, Luvisotto TB, Yeng LT, et al.Repetitive transcranial magnetic stimulation is efficacious as an add-on to pharmacological therapy in complex regional pain syndrome (CRPS) type I. Journal of Pain 2010;11(11):1203-10.
211. Pleger B, Janssen F, Schwenkreis P, Völker B, Maier C, Tegenthoff M. Repetitive transcranial magnetic stimulation of the motor cortex attenuates pain perception in complex regional pain syndrome type I. Pain 2004; Vol. 356:87-90.
212. Pleger B, Tegenthoff M, Ragert P, Förster A-F, Dinse HR, Schwenkreis P, et al.Sensorimotor returning in complex regional pain syndrome parallels pain reduction. Annals of Neurology 2005;57(3):425-9.
213. Pleger B, Ragert P, Schwenkreis P, Forster AF, Wilimzig C, Dinse H, et al.Patterns of cortical reorganization parallel impaired tactile discrimination and pain intensity in complex regional pain syndrome. Neuroimage 2006;32:503-10.
214. Prager JP. What does the mechanism of spinal cord stimulation tell us about complex regional pain syndrome?. Pain Medicine 2010;11(8):1278-83.
215. Price DD, Long S, Wilsey B, Rafii A. Analysis of peak magnitude and duration of analgesia produced by local anesthetics injected into sympathetic ganglia of complex regional pain syndrome patients. Clinical Journal of Pain 1998;14(3):216-26.
216. Ramamurthy S, Hoffman J. Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. Anesthesia and Analgesia 1995;81:718-23.
217. Rauck RL, Eisenach JC, Jackson K, Young LD, Southern J. Epidural clonidine treatment for refractory reflex sympathetic dystrophy. Anesthesiology 1993;79(6):1163-9.
218. Reinders MF, Geertzen JHB, Dijkstra PU. Complex regional pain syndrome type I: use of the international association for the study of pain diagnostic criteria defined in 1994. Clinical Journal of Pain 2002;18(4):207-15.
219. Robinson JN, Sandom J, Chapman PT. Efficacy of pamidronate in complex regional pain syndrome type I. Pain Medicine 2004;5(3):276-80.
220. Rocco AG, Kaul AF, Reisman RM, Gallo JP, Lief PA. A comparison of regional intravenous guanethidine and reserpine in reflex sympathetic dystrophy a controlled, randomized, double-blind crossover study. Clinical Journal of Pain 1989;5(3):205-9.
221. Sahin F, Yilmaz F, Kotevoglu N, Kuran B. Efficacy of salmon calcitonin in complex regional pain syndrome (type 1) in addition to physical therapy. Clinical Rheumatology 2006;25(2):143-8.
222. Sandroni P, Benrud-Larson LM, McClelland RL, Low PA. Complex regional pain syndrome type I: incidence and prevalence in Olmsted county, a population-based study. Pain 2003;103(1-2):199-207.
223. Schinkel C, Gaertner A, Zaspel J, Zedler S, Faist E, Schuermann M. Inflammatory mediators are altered in the acute phase of posttraumatic complex regional pain syndrome. Clinical Journal of Pain 2006;22(3):235-9.
224. Schmelz M, Weber M, Birklein F, Neundo B. Facilitated neurogenic inflammation in complex regional pain syndrome. Pain 2001;91:251-7.
225. Schwartzman RJ, Alexander GM, Grothusen JR, Paylor T, Reichenberger E, Perreault M. Outpatient intravenous ketamine for the treatment of complex regional pain syndrome: A double-blind placebo controlled study. Pain 2009; Vol. 147:107-15.
226. Schwenkreis P, Janssen F, Rommel O, Pleger B, Volker B, Hosbach I, et al.Bilateral motor cortex disinhibition in complex regional pain syndrome (CRPS) type I of the hand. Neurology 2003;61:515-9.
227. Shea BJ, Grimshaw JM, Wells G, Boers M, Andersson N, Hamel C, et al.Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Medical Research Methodology 2007;7:10.
228. Shipton EA. Complex regional pain syndrome: mechanisms, diagnosis, and management. Current Anaesthesia and Critical Care 2009;20:209-14.
229. Sigtermans MJ, van Hilten JJ, Bauer MCR, Arbous MS, Marinus J, Sarton EY, et al.Ketamine produces effective and long-term pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 2009; Vol. 145:304-11.
230. Stanton-Hicks MD, Burton AW, Bruehl SP, Carr DB, Harden RN, Hassenbusch SJ, et al.An updated interdisciplinary clinical pathway for CRPS: report of an expert panel. Pain Practice 2002;2(1):1-16.
231. Swart CMA, Stins JF, Beek PJ. Cortical changes in complex regional pain syndrome (CRPS). European Journal of Pain 2009;13(9):902-7.
232. Tan ECTH, Oyen WJG, Goris RJA. Leukocytes in complex regional pain syndrome type I. Inflammation 2005;29(4-6):182-6.
233. Taskaynatan AM, Ozgul A, Kenan Tan A, Dincer K, Alp Kalyon T. Bier block with methylprednisolone and lidocaine in CRPS type I: A randomized, double-blinded, placebo-controlled study. Regional Anesthesia and Pain Medicine 2004;29(5):408-12.
234. Turk DC, Dworkin RH, McDermott MP, Bellamy N, Burke LB, Chandler JM, et al.Analyzing multiple endpoints in clinical trials of pain treatments: IMMPACT recommendations. Pain 2008;139(3):485-93.
235. Turk DC, Dworkin RH, Revicki D, Harding G, Burke LB, Cella D, et al.Identifying important outcome domains for chronic pain clinical trials: An IMMPACT survey of people with pain. Pain 2008;137(2):276-85.
236. Uher EM, Vacariu G, Schneider B, Fialka V. Comparison of manual lymph drainage with physical therapy in complex regional pain syndrome type I. A comparative randomized controlled therapy study. Wiener klinische Wochenschrift [The Central European Journal of Medicine] 2000;112:133-7.
237. van de Vusse AC, Stomp-van den Berg SGM, Kessels AHF, Weber WE. Randomised controlled trial of gabapentin in Complex Regional Pain Syndrome type 1. BMC Neurology 2004; Vol. 4:13.
238. Varenna M, Zucchi F, Ghiringhelli D, Binelli L, Bevilacqua M, Bettica P, et al.Intravenous clodronate in the treatment of reflex sympathetic dystrophy syndrome. A randomized, double blind, placebo controlled study. Journal of Rheumatology 2000;27(6):1477-83.
239. Verdugo RJ, Moya MF, Cea JG, Salinas HA, Bilbeny CJ. Stellate ganglion block in reflex sympathetic dystrophy: a double-blind crossover study. Program & Abstracts of the 1st Scientific Meeting of the European Federation of IASP chapters. 1995.
240. Wallace MS, Ridgeway BM, Leung AY, Gerayli A, Yaksh TL. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology 2000;92(1):75-83.
241. Woolf CJ. Pain: moving from symptom control toward mechanism-specific pharmacologic management. Annals of Internal Medicine 2004;140(6):441-51.
242. Wu W, Bandilla E, Ciccone DS, Yang J, Cheng S-C S, Carner N, et al.Effects of qigong on late-stage complex regional pain syndrome. Alternative Therapies in Health and Medicine 1999;5(1):45-54.
243. Zuurmond WWA, Langendijk PNJ, Bezemer PD, Brink HEJ, De Lange JJ, Van Loenen AC. Treatment of acute reflex sympathetic dystrophy with DMSO 50% in a fatty cream. Acta Anaesthesiologica Scandinavica 1996;40(3):364-7.